Veeva Systems has acquired Crossix Solutions for $430 million, adding Crossix’s marketing analytics tools to its suite of cloud software.
Crossix will keep its brand and operate as an independent unit within Veeva. The unit will continue to be led by CEO Asaf Evenhaim. The deal is expected to close in November.
Veeva works with pharma and biotechs, providing cloud software and consulting services to support clinical, regulatory, medical and commercial parts of businesses. Its clients include Bayer, GlaxoSmithKline and Merck, as well as research nonprofits and consumer health companies.
With the addition of Crossix, Veeva will add its DIFA Platform, which ties healthcare marketing campaigns to data like patient behavior, medication adherence and healthcare provider prescribing. Crossix also provides patient and HCP targeting and audience insights.
Veeva posted $266.9 million in revenue, up 27% over the previous year, in its fiscal Q2, which ended on July 31. Its CFO, Tim Cabral, is set to retire next year, the company said last month.
